Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Catheter Precision Inc (AMEX: VTAK) closed at $0.42 in the last session, down -0.31% from day before closing price of $0.42. In other words, the price has decreased by -$0.31 from its previous closing price. On the day, 0.16 million shares were traded. VTAK stock price reached its highest trading level at $0.4188 during the session, while it also had its lowest trading level at $0.39.
Ratios:
We take a closer look at VTAK’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.65 and its Current Ratio is at 0.66. In the meantime, Its Debt-to-Equity ratio is 0.91 whereas as Long-Term Debt/Eq ratio is at 0.88.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Jaffray on August 13, 2019, Downgraded its rating to Neutral and sets its target price to $1.50 from $9 previously.
On November 02, 2018, Maxim Group started tracking the stock assigning a Buy rating and target price of $23.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 23 ’24 when JENKINS DAVID A bought 9,528 shares for $0.60 per share. The transaction valued at 5,694 led to the insider holds 329,856 shares of the business.
JENKINS DAVID A bought 9,528 shares of VTAK for $4,092 on Jan 22 ’24. The Executive Chairman and CEO now owns 320,328 shares after completing the transaction at $0.43 per share. On Jan 19 ’24, another insider, JENKINS DAVID A, who serves as the Executive Chairman and CEO of the company, bought 8,470 shares for $0.42 each. As a result, the insider paid 3,595 and bolstered with 310,800 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VTAK now has a Market Capitalization of 3351538 and an Enterprise Value of 1290376. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.37 while its Price-to-Book (P/B) ratio in mrq is 0.11. Its current Enterprise Value per Revenue stands at 2.96 whereas that against EBITDA is -0.15.
Stock Price History:
Over the past 52 weeks, VTAK has reached a high of $8.40, while it has fallen to a 52-week low of $0.31. The 50-Day Moving Average of the stock is -13.51%, while the 200-Day Moving Average is calculated to be -86.47%.
Shares Statistics:
According to the various share statistics, VTAK traded on average about 3.55M shares per day over the past 3-months and 473920 shares per day over the past 10 days. A total of 8.00M shares are outstanding, with a floating share count of 7.51M. Insiders hold about 6.22% of the company’s shares, while institutions hold 2.02% stake in the company. Shares short for VTAK as of 1730332800 were 183675 with a Short Ratio of 0.02, compared to 1727654400 on 46547. Therefore, it implies a Short% of Shares Outstanding of 183675 and a Short% of Float of 2.32.
